Can a urine test revolutionise how we diagnose asthma in kids? 💭🤔 We’re thrilled to be funding groundbreaking research that could change the way we diagnose asthma in preschoolers. The goal of the MAP-2 study is to enable earlier asthma diagnosis and safer, more appropriate treatment for wheezing children via a non-invasive urine test. Learn more 👉 https://lnkd.in/gSbydnWw
Perth Children’s Hospital (PCH) is participating in an important study aimed at improving asthma diagnosis for preschoolers. Our research team is collaborating with experts from Edith Cowan University on the MAP-2 study, led by Professor Andre Schultz, Respiratory Consultant at PCH. Asthma symptoms such as wheezing and shortness of breath are prevalent among young children, making accurate diagnosis essential. The MAP-2 study aims to transform this process through a non-invasive urine test, facilitating earlier and more precise diagnoses, and ensuring that treatment is appropriately targeted. As asthma remains a leading cause of hospitalisation for Australian children aged 0-4, it is crucial to identify those who genuinely require intervention, particularly given that approximately 70% of preschoolers may outgrow their wheezing. This study seeks to mitigate the risks associated with traditional steroid-based treatments. We extend our gratitude to Perth Children's Hospital Foundation whose funding has made this research possible. We look forward to sharing further updates soon. Professor Andre Schultz is pictured inside the PCH Atrium.